Division of Cancer Therapeutics
Carol Box has not added Biography.
If you are Carol Box and would like to personalize this page please email our Author Liaison for assistance.
The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.
Expert opinion on therapeutic targets Aug, 2005 | Pubmed ID: 16083342
Cell migration/invasion assays and their application in cancer drug discovery.
Biotechnology annual review , 2005 | Pubmed ID: 16216785
Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Cancer research Aug, 2007 | Pubmed ID: 17699797
Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck.
The Journal of pathology May, 2009 | Pubmed ID: 19197951
Tumour-microenvironmental interactions: paths to progression and targets for treatment.
Seminars in cancer biology Jun, 2010 | Pubmed ID: 20599506
MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) Mar, 2011 | Pubmed ID: 21074412
Angiogenic functions of voltage-gated Na+ Channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling.
The Journal of biological chemistry May, 2011 | Pubmed ID: 21385874
Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.
Molecular medicine (Cambridge, Mass.) , 2012 | Pubmed ID: 22354215
Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.
Journal of clinical immunology Oct, 2012 | Pubmed ID: 22526592
Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers.
Frontiers in bioscience (Landmark edition) , 2013 | Pubmed ID: 23276940
Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays.
Methods in molecular biology (Clifton, N.J.) , 2013 | Pubmed ID: 23436416
Tumor spheroid-based migration assays for evaluation of therapeutic agents.
Methods in molecular biology (Clifton, N.J.) , 2013 | Pubmed ID: 23436417
A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990) Jul, 2013 | Pubmed ID: 23582742
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。